Vestal Point Capital, LP Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$2.9T
Holdings
76
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (76 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ABVXAbivax SA | 1,900,000 | $256.2B | 8.71% | |
| 2 | NDQInvesco QQQ Trust Series 1 | 350,000 | $215.0B | 7.31% | Put |
| 3 | ACLXArcellx Inc | 2,925,000 | $190.7B | 6.48% | |
| 4 | TERNTerns Pharmaceuticals Inc | 4,500,000 | $181.8B | 6.18% | |
| 5 | BMRNBioMarin Pharmaceutical Inc | 3,000,000 | $178.3B | 6.06% | |
| 6 | GMEDGlobus Medical Inc | 1,275,000 | $111.3B | 3.78% | |
| 7 | NRIXNurix Therapeutics Inc | 4,690,000 | $89.0B | 3.02% | |
| 8 | ALCAlcon AG | 1,105,000 | $87.1B | 2.96% | |
| 9 | DC4Dexcom Inc | 1,275,000 | $84.6B | 2.88% | |
| 10 | MRKMerck & Co Inc | 775,000 | $81.6B | 2.77% | |
| 11 | TSHATaysha Gene Therapies Inc | 13,750,000 | $75.6B | 2.57% | |
| 12 | ABTAbbott Laboratories | 600,000 | $75.2B | 2.56% | |
| 13 | IMTXImmatics NV | 6,125,000 | $64.3B | 2.19% | |
| 14 | TYRATyra Biosciences Inc | 2,425,000 | $63.8B | 2.17% | |
| 15 | BCAXBicara Therapeutics Inc | 3,575,000 | $60.2B | 2.05% | |
| 16 | ARWRArrowhead Pharmaceuticals Inc | 900,000 | $59.8B | 2.03% | |
| 17 | ELVNEnliven Therapeutics Inc | 3,830,000 | $59.0B | 2.01% | |
| 18 | IRONDisc Medicine Inc | 735,000 | $58.4B | 1.98% | |
| 19 | JAZZJazz Pharmaceuticals PLC | 290,000 | $49.3B | 1.68% | |
| 20 | DAWNDay One Biopharmaceuticals Inc | 5,200,000 | $48.5B | 1.65% | |
| 21 | LXEOLexeo Therapeutics Inc | 4,475,000 | $44.4B | 1.51% | |
| 22 | ANROAlto Neuroscience Inc | 2,485,000 | $44.2B | 1.50% | |
| 23 | APGEApogee Therapeutics Inc | 550,000 | $41.5B | 1.41% | |
| 24 | OLMAOlema Pharmaceuticals Inc | 1,650,000 | $41.3B | 1.40% | |
| 25 | AXSMAxsome Therapeutics Inc | 210,000 | $38.4B | 1.30% | |
| 26 | ASNDAscendis Pharma A/S | 175,000 | $37.3B | 1.27% | |
| 27 | RAPPRapport Therapeutics Inc | 1,110,000 | $33.7B | 1.14% | |
| 28 | SLDBSolid Biosciences Inc | 5,815,000 | $32.8B | 1.12% | |
| 29 | TCE2Celldex Therapeutics Inc | 1,165,000 | $31.6B | 1.08% | |
| 30 | SRRKScholar Rock Holding Corp | 700,000 | $30.8B | 1.05% | |
| 31 | KALVKalVista Pharmaceuticals Inc | 1,890,000 | $30.5B | 1.04% | |
| 32 | VERAVera Therapeutics Inc | 550,000 | $27.9B | 0.95% | |
| 33 | XENEXenon Pharmaceuticals Inc | 600,000 | $26.9B | 0.91% | |
| 34 | LNTHLantheus Holdings Inc | 360,000 | $24.0B | 0.81% | |
| 35 | RVMDRevolution Medicines Inc | 295,000 | $23.5B | 0.80% | |
| 36 | ZYMEZymeworks Inc | 865,000 | $22.8B | 0.77% | |
| 37 | IMCRImmunocore Holdings PLC | 585,000 | $20.3B | 0.69% | |
| 38 | UPBUpstream Bio Inc | 720,000 | $19.5B | 0.66% | |
| 39 | BBNXBeta Bionics Inc | 600,000 | $18.3B | 0.62% | |
| 40 | CBIOCrescent Biopharma Inc | 1,500,000 | $17.8B | 0.60% | |
| 41 | BCRXBioCryst Pharmaceuticals Inc | 2,250,000 | $17.6B | 0.60% | |
| 42 | PENPenumbra Inc | 50,000 | $15.5B | 0.53% | |
| 43 | GONGeron Corp | 11,320,000 | $14.9B | 0.51% | |
| 44 | RGENRepligen Corp | 83,000 | $13.6B | 0.46% | |
| 45 | ZBHZimmer Biomet Holdings Inc | 150,000 | $13.5B | 0.46% | |
| 46 | BMYBristol-Myers Squibb Co | 250,000 | $13.5B | 0.46% | |
| 47 | GLUEMonte Rosa Therapeutics Inc | 775,000 | $12.2B | 0.41% | |
| 48 | FULCFulcrum Therapeutics Inc | 950,000 | $10.7B | 0.37% | |
| 49 | YB4PSavara Inc | 1,606,000 | $9.7B | 0.33% | |
| 50 | ENGNEngene Holdings Inc | 1,055,000 | $9.5B | 0.32% | |
| 51 | AGIOAgios Pharmaceuticals Inc | 325,000 | $8.8B | 0.30% | |
| 52 | BRD1EURDefinium Therapeutics Inc | 637,000 | $8.5B | 0.29% | |
| 53 | DNLIDenali Therapeutics Inc | 465,000 | $7.7B | 0.26% | |
| 54 | MYGNMyriad Genetics Inc | 1,223,000 | $7.5B | 0.26% | |
| 55 | TECXTectonic Therapeutic Inc | 328,000 | $6.8B | 0.23% | |
| 56 | NVCRNovocure Ltd | 525,000 | $6.8B | 0.23% | |
| 57 | MPLTMapLight Therapeutics Inc | 385,000 | $6.8B | 0.23% | |
| 58 | GILDGilead Sciences Inc | 50,000 | $6.1B | 0.21% | |
| 59 | VYGRVoyager Therapeutics Inc | 1,475,000 | $5.8B | 0.20% | |
| 60 | DBVTDBV Technologies SA | 300,000 | $5.8B | 0.20% | |
| 61 | MIRMMirum Pharmaceuticals Inc | 66,000 | $5.2B | 0.18% | |
| 62 | NYXHNyxoah SA | 1,107,000 | $5.1B | 0.17% | |
| 63 | NUVLNuvalent Inc | 46,000 | $4.6B | 0.16% | |
| 64 | LENZLENZ Therapeutics Inc | 275,000 | $4.4B | 0.15% | |
| 65 | RZLTRezolute Inc | 1,686,000 | $4.0B | 0.14% | |
| 66 | PASGPassage Bio Inc | 305,000 | $3.6B | 0.12% | |
| 67 | STROSutro Biopharma Inc | 243,000 | $2.8B | 0.10% | |
| 68 | GPCRStructure Therapeutics Inc | 35,000 | $2.4B | 0.08% | |
| 69 | DYNDyne Therapeutics Inc | 120,000 | $2.3B | 0.08% | |
| 70 | BDTXBlack Diamond Therapeutics Inc | 870,000 | $2.1B | 0.07% | |
| 71 | OKUROnKure Therapeutics Inc | 635,000 | $1.8B | 0.06% | |
| 72 | FATEFate Therapeutics Inc | 1,725,000 | $1.7B | 0.06% | |
| 73 | ALECAlector Inc | 755,000 | $1.2B | 0.04% | |
| 74 | TENXTenax Therapeutics Inc | 53,439 | $651.0M | 0.02% | |
| 75 | RGNXREGENXBIO Inc | 34,000 | $489.0M | 0.02% | |
| 76 | MGNXMacroGenics Inc | 280,000 | $450.0M | 0.02% |